Page 34 - Markets

Anupam Rasayan shares climb as it enters US CDMO via Jayhawk Fine deal

Anupam Rasayan climbed on the BSE after announcing the acquisition of Jayhawk Fine Chemicals for $150 million, a deal analysts say could be value-accretive over the medium term

IndiGo, Hindustan Unilever: 4 Nifty stocks with RSI in oversold territory

Technical charts show that stocks such as IndiGo, Hindustan Unilever, Apollo Hospitals and Tata Motors Passenger Vehicles are trading in oversold territory based on the RSI parameter.

Meesho Share Price Today: Stock trades at 60% premium after strong listing; should you book profit?

Meesho Share Price Today: Post-listing, Meesho shares continue to trade higher on the bourses on Wednesday

Zydus Lifesciences shares rise 2% on expanding its biosimilar portfolio

Zydus Lifesciences shares rose 2 per cent on Wednesday after it announced two key developments aimed at expanding its biosimilar portfolio

Meesho lists at 46% premium; analysts upbeat on long-term view; here's why

Choice Equity Broking has initiated coverage on Meesho with a 'Buy' rating, citing the company's structural competitive Moats, strong monetisation runway, and accelerating path to profitability

Vidya Wires makes flat D-street debut at ₹52; misses GMP estimates

Ahead of debut, Vidya Wires shares were quoting at ₹55.5 in the grey market, reflecting a premium of ₹3.5 or 6.7 per cent over the issue price

Godrej Industries shares rise as unit signs MoU with Telangana govt

Godrej Industries shares rose after its subsidiary signed a MoU with the Telangana government to invest ₹150 crore in a new dairy processing facility

Kalpataru Projects shares gain 3% on winning orders worth ₹2,003 crore

Kalpataru Projects has secured new orders worth about ₹2,003 crore across its buildings, factories and power transmission businesses

Siemens LVM business sale 'value-accretive'; JM Financial ups target price

JM Financial has a 'Add' rating and raised its target price on Siemens "modestly" to ₹3,480, reflecting higher expected other income

Park Medi World IPO opens for bidding; check GMP, price band, dates, review

Park Medi World raised ₹276 crore from 23 institutional investors via an anchor book on December 5

Nifty, Bank Nifty outlook; AB Capital, Federal Bank on analyst radar today

AB Capital is in overall uptrend and perfectly respecting 20 DEMA, while Federal Bank has given consolidation breakout on daily chart and formed a strong bullish candle

Gujarat Pipavav, ESAB India among top stocks to buy today; check key levels

Kunal Kamble, senior technical research analyst at Bonanza, has recommended buying shares of Gujarat Pipavav, Ashapura Minechem, and ESAB India today

Trading guide, Dec 10: Check key Nifty levels to watch; two stocks to buy

During the weekly expiry session, Nifty witnessed heightened volatility and ended the day at 25,839, down 120 points

Elara bets on NTPC, Power Grid; sees hydro sector on strong long-term path

Elara prefers regulated public-sector utilities such as NTPC and Power Grid Corporation, citing assured returns from regulated assets and a strong capacity-addition pipeline

IPOs worth $20 billion per annum are the 'new normal' for India: JP Morgan

Initial public offerings worth USD 20 billion per annum are the "new normal" for India and will become an annualised run rate over the next few years, one of the biggest investment bankers said on Tuesday. The market, which has seen a slew of initial share sales this fiscal, has already witnessed USD 21 billion of issuances in 2025, the same as last year, and we should close the year with over USD 23 billion, given the fact that some large issues like the Rs 10,000 offering from ICICI Prudential AMC are in process, said JP Morgan. "Yearly issuance of USD 20 billion is the new normal for India. It is the new watermark and will become an annualized run rate from here on," its head of equity capital markets, Abhinav Bharti, told reporters here. Bharti said nearly a fifth of the demand is getting driven by consumer technology and new age businesses, and the same will go above 30 per cent as well over the next five years. He said at least 20 startups, which command valuations in hundred

Synergy gains from stake purchase positive for pharma major Biocon

Brokerages say Biocon's move to fully acquire Biocon Biologics simplifies structure and unlocks value, but near-term stock pressure likely due to dilution and fundraising

Nephrocare Health IPO opens Dec 10: Should you bid? Here's what experts say

Nephrocare Health IPO comprises a fresh issue of 7.7 million, amounting to ₹353.4 crore and an offer for sale (OFS) of 11.3 million equity shares amounting to ₹517.64 crore

Park Medi World IPO: Analysts split on prospects; should you apply?

The three-day subscription window to bid for the Park Medi World IPO will close on Friday, December 12, 2025

Ajmera Realty shares gain 4% as new project sees 81% sell-out in 24 hours

Ajmera Realty shares rose 4 per cent after it launched a premium and mid-segment residential project and recorded an 81 per cent sell-out within hours

Aequs IPO listing on December 10: Here's what latest GMP indicates

Ahead of its listing, the unlisted shares of Aequs were trading at around ₹152 per share in the grey market, indicating a premium of ₹28 or 22.6 per cent